Vous voulez être sûr que vos cadeaux seront sous le sapin de Noël à temps? Nos magasins vous accueillent à bras ouverts. La plupart de nos magasins sont ouverts également les dimanches, vous pouvez vérifier les heures d'ouvertures sur notre site.
- Retrait gratuit dans votre magasin Club
- 7.000.000 titres dans notre catalogue
- Payer en toute sécurité
- Toujours un magasin près de chez vous
Vous voulez être sûr que vos cadeaux seront sous le sapin de Noël à temps? Nos magasins vous accueillent à bras ouverts. La plupart de nos magasins sont ouverts également les dimanches, vous pouvez vérifier les heures d'ouvertures sur notre site.
- Retrait gratuit dans votre magasin Club
- 7.000.0000 titres dans notre catalogue
- Payer en toute sécurité
- Toujours un magasin près de chez vous
New Treatments for Addiction
Behavioral, Ethical, Legal, and Social Questions
National Research Council, Institute of Medicine, Board on Neuroscience and Behavioral Health, Board on Health Promotion and Disease Prevention, Division of Behavioral and Social Sciences and Education, Board on Behavioral Cognitive and Sensory Sciences, Committee on Immunotherapies and Sustained-Release Formulations
Livre broché | Anglais
46,45 €
+ 92 points
Description
New and improved therapies to treat and protect against drug dependence and abuse are urgently needed. In the United States alone about 50 million people regularly smoke tobacco and another 5 million are addicted to other drugs. In a given year, millions of these individuals attempt--with or without medical assistance--to quit using drugs, though relapse remains the norm. Furthermore, each year several million teenagers start smoking and nearly as many take illicit drugs for the first time. Research is advancing on promising new means of treating drug addiction using immunotherapies and sustained-release (depot) medications. The aim of this research is to develop medications that can block or significantly attenuate the psychoactive effects of such drugs as cocaine, nicotine, heroin, phencyclidine, and methamphetamine for weeks or months at a time. This represents a fundamentally new therapeutic approach that shows promise for treating drug addiction problems that were difficult to treat in the past. Despite their potential benefits, however, several characteristics of these new methods pose distinct behavioral, ethical, legal, and social challenges that require careful scrutiny. Such issues can be considered unique aspects of safety and efficacy that are fundamentally related to the distinct nature and properties of these new types of medications.
Spécifications
Parties prenantes
- Auteur(s) :
National Research CouncilInstitute of MedicineBoard on Neuroscience and Behavioral HealthBoard on Health Promotion and Disease PreventionDivision of Behavioral and Social Sciences and EducationBoard on Behavioral Cognitive and Sensory SciencesCommittee on Immunotherapies and Sustained-Release Formulations
- Editeur:
Contenu
- Nombre de pages :
- 320
- Langue:
- Anglais
Caractéristiques
- EAN:
- 9780309091282
- Date de parution :
- 03-07-04
- Format:
- Livre broché
- Format numérique:
- Trade paperback (VS)
- Dimensions :
- 164 mm x 228 mm
- Poids :
- 512 g
